REPLY
16.7.2024 09:31:28 CEST | Business Wire | Press release
Roboverse Reply, the Reply Group company specialising in integration scenarios around Robotics and Reality Capture with Mixed Reality, has received the “Best Performance” award in the Recon Challenge at the European Land Robot Trial (ELROB) 2024, demonstrating how autonomous mobile robots enable remote reconnaissance missions. ELROB is Europe's most rigorous and longest-established field robotics and unmanned systems event, where leading robotics experts from around the world compete with their latest advancements across various disciplines. Roboverse Reply once again stood out with its robotics platform and VR interface, with which the experts recently also won this year's AIRA Challenge, an international contest for advanced solutions in autonomous inspection of industrial environments.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240716179693/en/
Roboverse Reply, the Reply Group company specialising in integration scenarios around Robotics and Reality Capture with Mixed Reality, has received the “Best Performance” award in the Recon Challenge at the European Land Robot Trial (ELROB) 2024, demonstrating how autonomous mobile robots enable remote reconnaissance missions. (Photo: Business Wire)
The Roboverse Reply team, with EPL's team, specialised in technical equipment for defusing services, focused on an autonomous solution for spaces recognition. Thanks to state-of-the-art AI technology and advanced sensor technology, Roboverse Reply’s platform allows users to navigate mobile robots such as Spot® from Boston Dynamics remotely through dangerous areas via VR glasses and perform tasks on site. In addition to thermal, depth and X-ray images, the robot also provides full-colour 3D scans and thus essential information about the surroundings and possible obstacles for the rescue team. All this information is combined in the VR system in real-time and enables intuitive and precise movement of the robot arm using the VR controller.
Filippo Rizzante, CTO of Reply, commented: "Winning the ELROB Recon and AIRA challenges proves the versatility of Roboverse Reply's robotics platform. Autonomous inspection of production plants and reconnaissance missions are just two examples of how it significantly increases efficiency and safety by improving the interface between humans and robots through VR control. We are constantly developing new solutions in the fields of Spatial Computing and Embodied AI so that our customers can receive even more tailored information and support for their use cases across various industries".
Reply
Reply [EXM, STAR: REY] specialises in the design and implementation of solutions based on new communication channels and digital media. As a network of highly specialised companies, Reply defines and develops business models enabled by the new models of AI, big data, cloud computing, digital media and the internet of things. Reply delivers consulting, system integration and digital services to organisations across the telecom and media; industry and services; banking and insurance; and public sectors. www.reply.com
Roboverse Reply
Roboverse Reply specializes in the integration scenarios around Robotics and Reality Capture with Mixed Reality, where Cloud or On-Premises Infrastructures require Enterprise-Ready solutions. Roboverse Reply solutions include AI Skills with sensor-based anomaly detection, Fleet Management for Internet of Robotic Things, Digital Twins and Business Logic to deliver end-to-end support for the customers. The Roboverse Reply platform enables Autonomous Preventive Inspection to prolong the lifespan of your infrastructures and interactive telepresence, crucial for Safety and Security purposes. www.roboverse.reply.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240716179693/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
First Randomized Controlled Trial Shows Promise of a Ketogenic Diet in Psychotic Disorders8.7.2026 15:00:00 CEST | Press release
Trial reports correlations between ketone levels and cognitive and psychiatric symptoms in individuals with schizophrenia-spectrum and bipolar-1 disorders Published today in Schizophrenia Bulletin, a first-of-its-kind randomized controlled trial (RCT) from researchers at the University of California, San Francisco (UCSF), and funded in part by the National Institute of Mental Health (NIMH), adds to growing literature on the potential benefit of a ketogenic diet for treating psychotic disorders. The study, which enrolled participants with schizophrenia-spectrum or bipolar-1 disorders, demonstrated rapid metabolic improvements with a ketogenic diet compared to diet-as-usual during an initial one-month RCT open-label phase. Furthermore, those who continued with the optional four-month single-arm ketogenic diet extension saw meaningful gains across metabolic, psychiatric, and cognitive measures. This press release features multimedia. View the full release here: https://www.businesswire.co
Teamily AI Publicly Launches Human+AI Social Platform to Make Building and Growing a Company Easy for Every Team8.7.2026 15:00:00 CEST | Press release
Teamily AI (https://Teamily.ai), together with its Agentic AI Infra platform TensorOpera AI (https://TensorOpera.ai), today announced the public launch of its Human+AI social platform, a product stack that has already served more than 5 million users around the world. Starting today in Palo Alto and rolling out simultaneously across dozens of countries, this first public launch opens the full stack to everyone with a single mission: to make building and growing a company easy for every person and every team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708584390/en/ "This is the moment we open our doors to the world," said co-founders Dr. Aiden Chaoyang He and Professor Salman Avestimehr. "We want every person and every team to be able to move from idea to product, from product to market, and from market to growth and investment, with an AI-native team by their side." At its core, Teamily AI enables humans and AI agents
Leo Cancer Care Raises $65M Series D to Scale Its Integrated Upright Cancer Care Platform8.7.2026 14:30:00 CEST | Press release
Oversubscribed round follows the world-first compact upright proton treatment at Stanford Medicine — funding a single upright platform that will span imaging and treatment across multiple radiation modalities. Leo Cancer Care, the medical technology company working to reinvent how patients are imaged and treated by designing systems around the body’s natural upright position, today announced the close of an oversubscribed $65 million Series D financing. The round was led by Silicon Valley’s Yu Galaxy and welcomes new investors including Eventide Asset Management, alongside continued support from the company’s existing investors. Leading cancer institutions are already adopting the upright approach. Stanford Medicine delivered the world’s first compact upright proton therapy treatment on 4 June 2026. Dana-Farber Cancer Institute and McLaren Health Care are among the institutions bringing the upright platform into their programmes — adoption that spans world-leading academic centers and
LUMI AI Factory Selects IQM to Deploy Advanced Quantum Computer, Accelerating Hybrid HPC and AI Development8.7.2026 14:00:00 CEST | Press release
The Halocene H4 quantum computer, named LUMI-IQ, will be delivered and installed in 2027 The system will be hosted at CSC – IT Center for Science in Finland and integrated into the LUMI AI Factory The system will provide researchers, industry innovators, and developers across Europe with a unique, advanced experimental platform where quantum computing and artificial intelligence converge The LUMI AI Factory, led by CSC – IT Center for Science, has selected IQM Quantum Computers (Nasdaq: IQMX) to deliver IQM Halocene H4, an advanced quantum computer aimed at accelerating hybrid high-performance computing, artificial intelligence, and quantum computing capabilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708006791/en/ LUMI AI Factory selects IQM to deploy advanced quantum computer, accelerating hybrid HPC and AI development IQM Halocene H4 is the first and most advanced on-premises superconducting quantum computer o
Merck Announces FDA Breakthrough Therapy Designation for Enpatoran in Lupus Patients With Active Skin Manifestations8.7.2026 14:00:00 CEST | Press release
Enpatoran could address a significant unmet need in lupus, specifically targeting cutaneous manifestations of the disease, which currently have no approved therapiesFDA's decision was supported by Phase 2 WILLOW study results, which demonstrated meaningful symptoms improvement, particularly among patients with active cutaneous manifestationsEnpatoran's potential to go beyond current treatment standards in lupus prompted FDA´s breakthrough designation, which is designed to expedite drug development and reviewNot intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to enpatoran for the treatment of lupus with active cutaneous manifestations. Enpatoran is an oral selective toll-like receptor (TLR) 7/8 inhibitor, designed to modulate pathways central to lupus-related inflammation. “For the 85% of lupus patients whose disease includes skin manif
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom